MRD Status May Outweigh Cytogenetic Risk as Prognostic Marker for Myeloma

Minimal residual disease negativity measured by next-generation sequencing was a valuable prognostic biomarker for multiple myeloma.

Source: CancerNetwork - October 5, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news